MGI Partners with National Cancer Centre Singapore to Undergo Comprehensive Genomic Profiling of Asian-Prevalent Cancers

MGI Tech Singapore Pte, Ltd. (“MGI”), a company committed to building core tools and technology to lead life science, recently entered a research partnership with National Cancer Centre Singapore (“NCCS”) to facilitate comprehensive, multi-dimensional genomic profiling of Asian-prevalent cancers using MGI’s core DNBSEQ™ technology.

Corundum Neuroscience Launches Neuroscience Venture Builder & Fund

What You Should Know: – Corundum Neuroscience, formerly Joy Ventures launches a new neuroscience-focused venture builder and fund to spur neuroscience research and innovation. –

November 9, 2023

Newsom Moves California Toward Psychedelic Therapy | Psychedelic Invest

Last fall, California Governor Gavin Newsom expressed readiness to integrate psychedelic drugs into the state’s mental health treatment framework. Following this, Senators Scott Wiener and

February 6, 2024

Healthy eating may be a key player in COPD risk reduction

The association between diet quality and the odds of Chronic obstructive pulmonary disease (COPD).

October 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.